

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 7.61576872 |
| 2 | negative thymic T cell selection (GO:0045060) | 6.97637600 |
| 3 | NIK/NF-kappaB signaling (GO:0038061) | 6.86516438 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.85716193 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.21059194 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.96467388 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.91728614 |
| 8 | positive T cell selection (GO:0043368) | 5.75659396 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.44816269 |
| 10 | thymic T cell selection (GO:0045061) | 5.43898891 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36914393 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.34133146 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.34133146 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 5.33478371 |
| 15 | leukocyte aggregation (GO:0070486) | 5.27144867 |
| 16 | activated T cell proliferation (GO:0050798) | 5.14623766 |
| 17 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.92902186 |
| 18 | T cell selection (GO:0045058) | 4.87921868 |
| 19 | response to pheromone (GO:0019236) | 4.81313071 |
| 20 | interferon-gamma production (GO:0032609) | 4.79472259 |
| 21 | T cell mediated immunity (GO:0002456) | 4.72748762 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.70160291 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.69580837 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.52141253 |
| 25 | response to interleukin-15 (GO:0070672) | 4.51423338 |
| 26 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.50660233 |
| 27 | T cell migration (GO:0072678) | 4.46860055 |
| 28 | regulation of chronic inflammatory response (GO:0002676) | 4.37437066 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 4.32765263 |
| 30 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.31939835 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 4.28311103 |
| 32 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.27555063 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.23603280 |
| 34 | tolerance induction (GO:0002507) | 4.13539749 |
| 35 | positive regulation of tolerance induction (GO:0002645) | 4.12940962 |
| 36 | regulation of cell killing (GO:0031341) | 4.03760239 |
| 37 | positive regulation of cell killing (GO:0031343) | 4.00832742 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.99049874 |
| 39 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.98309671 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97842085 |
| 41 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.95887709 |
| 42 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.95887709 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.94552471 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.90654412 |
| 45 | regulation of necroptotic process (GO:0060544) | 3.85320262 |
| 46 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.80197183 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.78628286 |
| 48 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.70158906 |
| 49 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.69678803 |
| 50 | alpha-beta T cell differentiation (GO:0046632) | 3.69336125 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 3.68929640 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.68003997 |
| 53 | T cell differentiation involved in immune response (GO:0002292) | 3.66907276 |
| 54 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.66907276 |
| 55 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.66907276 |
| 56 | actin nucleation (GO:0045010) | 3.64828978 |
| 57 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.60466600 |
| 58 | T-helper cell differentiation (GO:0042093) | 3.60466600 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.60426172 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59632075 |
| 61 | positive regulation of DNA recombination (GO:0045911) | 3.57762671 |
| 62 | negative regulation of necroptotic process (GO:0060546) | 3.50011211 |
| 63 | T cell receptor signaling pathway (GO:0050852) | 3.45260658 |
| 64 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.42349974 |
| 65 | regulation of T cell mediated immunity (GO:0002709) | 3.39716071 |
| 66 | T cell homeostasis (GO:0043029) | 3.36842465 |
| 67 | positive regulation of T cell mediated immunity (GO:0002711) | 3.36778455 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33376346 |
| 69 | negative regulation of stress fiber assembly (GO:0051497) | 3.31628621 |
| 70 | regulation of defense response to virus by virus (GO:0050690) | 3.30242778 |
| 71 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.29613376 |
| 72 | T cell differentiation (GO:0030217) | 3.22273575 |
| 73 | alpha-beta T cell activation (GO:0046631) | 3.20244038 |
| 74 | positive regulation of isotype switching (GO:0045830) | 3.19609360 |
| 75 | defense response to protozoan (GO:0042832) | 3.16466191 |
| 76 | lymphocyte costimulation (GO:0031294) | 3.16062269 |
| 77 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.14331772 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 3.13610182 |
| 79 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.13436704 |
| 80 | lymphocyte migration (GO:0072676) | 3.12957135 |
| 81 | mast cell activation (GO:0045576) | 3.11962874 |
| 82 | cytidine metabolic process (GO:0046087) | 3.11837946 |
| 83 | cytidine catabolic process (GO:0006216) | 3.11837946 |
| 84 | cytidine deamination (GO:0009972) | 3.11837946 |
| 85 | DNA deamination (GO:0045006) | 3.08682914 |
| 86 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.05713661 |
| 87 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.04908172 |
| 88 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.04583916 |
| 89 | T cell costimulation (GO:0031295) | 3.03665129 |
| 90 | positive regulation of interleukin-10 production (GO:0032733) | 3.01244909 |
| 91 | tachykinin receptor signaling pathway (GO:0007217) | 2.98955881 |
| 92 | type I interferon signaling pathway (GO:0060337) | 2.98865888 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.98865888 |
| 94 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.98572546 |
| 95 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.97042838 |
| 96 | response to type I interferon (GO:0034340) | 2.94926621 |
| 97 | positive regulation of interleukin-4 production (GO:0032753) | 2.93542504 |
| 98 | S-adenosylmethionine metabolic process (GO:0046500) | 2.93497801 |
| 99 | regulation of T cell apoptotic process (GO:0070232) | 2.93080747 |
| 100 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91545967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.84423905 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.46109306 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.76071761 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.10279182 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.99196662 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66381148 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64326159 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.56471663 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.46573535 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.16991444 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.91620568 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.89321299 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.89293928 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.80808832 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.67266151 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45820534 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.41210920 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.40834250 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.40284578 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.28838743 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.26861239 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19643016 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08640922 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05321475 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97308938 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94067052 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86969745 |
| 28 | GATA3_26560356_Chip-Seq_TH2_Human | 1.86316683 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.83046614 |
| 30 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.80823153 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73138645 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56651908 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47315305 |
| 34 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.42070584 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41831274 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41537176 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38572283 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36463041 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28412742 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26151618 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24436329 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20494015 |
| 43 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.18615923 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16524529 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.14658198 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10819162 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10652807 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08380248 |
| 49 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07125282 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04184893 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03332591 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02675204 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02657619 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02524419 |
| 55 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98629097 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96993017 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95578669 |
| 58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95560763 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93352278 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93121862 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91119470 |
| 62 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90466805 |
| 63 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89428027 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 0.87537553 |
| 65 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85699976 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85319859 |
| 67 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84424229 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83960946 |
| 69 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82617249 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82189981 |
| 71 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82034362 |
| 72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81764841 |
| 73 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.81269772 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80095469 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78445824 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76715596 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76163084 |
| 78 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75943802 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75850580 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75502219 |
| 81 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73664629 |
| 82 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.73339887 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.73339887 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.72611576 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70051097 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.69671450 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68935879 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67660188 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67514730 |
| 90 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.66286515 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66114106 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.64935627 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64760726 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.64592287 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.64240461 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63894231 |
| 97 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.63431908 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.62190079 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.61872104 |
| 100 | ERA_21632823_ChIP-Seq_H3396_Human | 0.60331820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.09593308 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.05693483 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.88256324 |
| 4 | MP0001348_abnormal_lacrimal_gland | 3.45906235 |
| 5 | MP0000685_abnormal_immune_system | 3.27190925 |
| 6 | MP0003436_decreased_susceptibility_to | 3.13012544 |
| 7 | MP0006082_CNS_inflammation | 3.00950049 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.94113583 |
| 9 | MP0001800_abnormal_humoral_immune | 2.92438134 |
| 10 | MP0001873_stomach_inflammation | 2.82203580 |
| 11 | MP0009785_altered_susceptibility_to | 2.69016348 |
| 12 | MP0003646_muscle_fatigue | 2.68549031 |
| 13 | MP0005387_immune_system_phenotype | 2.63447982 |
| 14 | MP0001790_abnormal_immune_system | 2.63447982 |
| 15 | MP0005025_abnormal_response_to | 2.58218893 |
| 16 | MP0002723_abnormal_immune_serum | 2.52176989 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.50733063 |
| 18 | MP0001819_abnormal_immune_cell | 2.47740646 |
| 19 | MP0003724_increased_susceptibility_to | 2.45114271 |
| 20 | MP0002163_abnormal_gland_morphology | 2.43870901 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.43046641 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.41797809 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.23433956 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.19702856 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 2.18890596 |
| 26 | MP0001986_abnormal_taste_sensitivity | 2.13501486 |
| 27 | MP0002398_abnormal_bone_marrow | 2.02294665 |
| 28 | MP0002419_abnormal_innate_immunity | 1.99310237 |
| 29 | MP0000716_abnormal_immune_system | 1.97103155 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.95249714 |
| 31 | MP0002933_joint_inflammation | 1.93042816 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.88789292 |
| 33 | MP0003866_abnormal_defecation | 1.86806613 |
| 34 | MP0002405_respiratory_system_inflammati | 1.85621842 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.80580905 |
| 36 | MP0002132_abnormal_respiratory_system | 1.70995849 |
| 37 | MP0000604_amyloidosis | 1.66930607 |
| 38 | MP0002006_tumorigenesis | 1.64940159 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.64140043 |
| 40 | MP0003252_abnormal_bile_duct | 1.58538406 |
| 41 | MP0002722_abnormal_immune_system | 1.55676519 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.55603479 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.53421556 |
| 44 | MP0002429_abnormal_blood_cell | 1.46814630 |
| 45 | MP0005410_abnormal_fertilization | 1.45442226 |
| 46 | MP0008872_abnormal_physiological_respon | 1.42967970 |
| 47 | MP0004947_skin_inflammation | 1.41478628 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.38629965 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.34672710 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29396937 |
| 51 | MP0005310_abnormal_salivary_gland | 1.25823483 |
| 52 | MP0008469_abnormal_protein_level | 1.24595893 |
| 53 | MP0002009_preneoplasia | 1.13678349 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.07106989 |
| 55 | MP0002693_abnormal_pancreas_physiology | 1.06933622 |
| 56 | MP0005451_abnormal_body_composition | 1.05354372 |
| 57 | MP0005083_abnormal_biliary_tract | 1.02647816 |
| 58 | MP0009764_decreased_sensitivity_to | 1.01934543 |
| 59 | MP0003690_abnormal_glial_cell | 1.01653258 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.01522232 |
| 61 | MP0004381_abnormal_hair_follicle | 0.99626071 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 0.94263547 |
| 63 | MP0001765_abnormal_ion_homeostasis | 0.92672236 |
| 64 | MP0002396_abnormal_hematopoietic_system | 0.91377450 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 0.89574021 |
| 66 | MP0003303_peritoneal_inflammation | 0.89370852 |
| 67 | MP0003075_altered_response_to | 0.88198951 |
| 68 | MP0005166_decreased_susceptibility_to | 0.87948548 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.87916914 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.87172799 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.86006441 |
| 72 | MP0005423_abnormal_somatic_nervous | 0.85966685 |
| 73 | MP0002928_abnormal_bile_duct | 0.76615427 |
| 74 | MP0000858_altered_metastatic_potential | 0.75987324 |
| 75 | MP0010329_abnormal_lipoprotein_level | 0.72944154 |
| 76 | MP0002736_abnormal_nociception_after | 0.70217610 |
| 77 | MP0004130_abnormal_muscle_cell | 0.68208101 |
| 78 | MP0001501_abnormal_sleep_pattern | 0.66884697 |
| 79 | MP0001663_abnormal_digestive_system | 0.63894664 |
| 80 | MP0004142_abnormal_muscle_tone | 0.63730744 |
| 81 | MP0003448_altered_tumor_morphology | 0.61485409 |
| 82 | MP0000920_abnormal_myelination | 0.59572710 |
| 83 | MP0009763_increased_sensitivity_to | 0.57211272 |
| 84 | MP0001346_abnormal_lacrimal_gland | 0.55950733 |
| 85 | MP0000249_abnormal_blood_vessel | 0.54320278 |
| 86 | MP0005165_increased_susceptibility_to | 0.52435588 |
| 87 | MP0005390_skeleton_phenotype | 0.51536593 |
| 88 | MP0008874_decreased_physiological_sensi | 0.50405332 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.50058769 |
| 90 | MP0003795_abnormal_bone_structure | 0.48916445 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.48515965 |
| 92 | MP0001851_eye_inflammation | 0.48473011 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.47591964 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.47321171 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.44831323 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.44133585 |
| 97 | MP0001542_abnormal_bone_strength | 0.41442989 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.40910558 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.40323445 |
| 100 | MP0002102_abnormal_ear_morphology | 0.40109293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.01719008 |
| 2 | Severe combined immunodeficiency (HP:0004430) | 5.55365727 |
| 3 | T lymphocytopenia (HP:0005403) | 5.48511147 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.31644925 |
| 5 | IgG deficiency (HP:0004315) | 5.22249469 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.86629120 |
| 7 | Aplastic anemia (HP:0001915) | 4.75710284 |
| 8 | Hypoproteinemia (HP:0003075) | 4.64155964 |
| 9 | Abnormality of T cells (HP:0002843) | 4.61889377 |
| 10 | Combined immunodeficiency (HP:0005387) | 4.40237680 |
| 11 | Eczematoid dermatitis (HP:0000976) | 4.35633251 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.24196816 |
| 13 | Autoimmune hemolytic anemia (HP:0001890) | 4.22714441 |
| 14 | Chronic diarrhea (HP:0002028) | 4.02573403 |
| 15 | Oral leukoplakia (HP:0002745) | 3.90524267 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89347477 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.82110432 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 3.77067904 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.73374821 |
| 20 | Increased IgM level (HP:0003496) | 3.70757250 |
| 21 | Optic neuritis (HP:0100653) | 3.64922330 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.64922330 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.63054448 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.63054448 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.57067387 |
| 26 | Myositis (HP:0100614) | 3.49420297 |
| 27 | Thyroiditis (HP:0100646) | 3.41832806 |
| 28 | Recurrent bronchitis (HP:0002837) | 3.37948253 |
| 29 | Orchitis (HP:0100796) | 3.36768930 |
| 30 | Encephalitis (HP:0002383) | 3.24090824 |
| 31 | Abnormality of eosinophils (HP:0001879) | 3.21165904 |
| 32 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.11793283 |
| 33 | Hypoplasia of the pons (HP:0012110) | 3.04663416 |
| 34 | Abnormality of the pons (HP:0007361) | 3.00727115 |
| 35 | Increased muscle lipid content (HP:0009058) | 2.94287282 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.89222008 |
| 37 | Neonatal respiratory distress (HP:0002643) | 2.79714507 |
| 38 | Slow saccadic eye movements (HP:0000514) | 2.77883434 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.77742270 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.72990124 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 2.66485420 |
| 42 | Leukocytosis (HP:0001974) | 2.63746813 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.59298181 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.58484124 |
| 45 | Bronchitis (HP:0012387) | 2.58433747 |
| 46 | Meningitis (HP:0001287) | 2.49818289 |
| 47 | Loss of speech (HP:0002371) | 2.48233350 |
| 48 | Recurrent viral infections (HP:0004429) | 2.48183786 |
| 49 | Vasculitis (HP:0002633) | 2.44838983 |
| 50 | Lymphopenia (HP:0001888) | 2.44568244 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41419201 |
| 52 | Hypoalbuminemia (HP:0003073) | 2.41042926 |
| 53 | Abnormal albumin level (HP:0012116) | 2.41042926 |
| 54 | Recurrent skin infections (HP:0001581) | 2.40571810 |
| 55 | Mesangial abnormality (HP:0001966) | 2.39035918 |
| 56 | Eosinophilia (HP:0001880) | 2.37477797 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.36896308 |
| 58 | Hypergammaglobulinemia (HP:0010702) | 2.36074964 |
| 59 | B lymphocytopenia (HP:0010976) | 2.34658290 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.34109821 |
| 61 | Radial bowing (HP:0002986) | 2.32572150 |
| 62 | Nasal polyposis (HP:0100582) | 2.32554519 |
| 63 | Hemoptysis (HP:0002105) | 2.31931365 |
| 64 | Joint swelling (HP:0001386) | 2.29088930 |
| 65 | Increased IgE level (HP:0003212) | 2.22601290 |
| 66 | Granulocytopenia (HP:0001913) | 2.22599622 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.19563587 |
| 68 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.18751530 |
| 69 | IgM deficiency (HP:0002850) | 2.18687749 |
| 70 | Fatigue (HP:0012378) | 2.17161004 |
| 71 | Chronic otitis media (HP:0000389) | 2.14993257 |
| 72 | Pustule (HP:0200039) | 2.13745307 |
| 73 | Lymphoma (HP:0002665) | 2.13226521 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.12220003 |
| 75 | Lipid accumulation in hepatocytes (HP:0006561) | 2.10815934 |
| 76 | Abnormality of B cell number (HP:0010975) | 2.09757145 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.09275975 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07701186 |
| 79 | Obstructive lung disease (HP:0006536) | 2.07701186 |
| 80 | Pancytopenia (HP:0001876) | 2.07623800 |
| 81 | Gangrene (HP:0100758) | 2.02422158 |
| 82 | Congenital stationary night blindness (HP:0007642) | 2.00127659 |
| 83 | Recurrent otitis media (HP:0000403) | 1.99534500 |
| 84 | Xanthomatosis (HP:0000991) | 1.97969472 |
| 85 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94173169 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 1.93507334 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 1.92588857 |
| 88 | Dyskinesia (HP:0100660) | 1.92540112 |
| 89 | Exertional dyspnea (HP:0002875) | 1.91088741 |
| 90 | IgA deficiency (HP:0002720) | 1.91049969 |
| 91 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.90119880 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 1.90009541 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 1.88908326 |
| 94 | Anorexia (HP:0002039) | 1.88808531 |
| 95 | Hypochromic anemia (HP:0001931) | 1.87368153 |
| 96 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83978476 |
| 97 | Neutropenia (HP:0001875) | 1.80777476 |
| 98 | Inflammation of the large intestine (HP:0002037) | 1.80712397 |
| 99 | Bronchiectasis (HP:0002110) | 1.80335449 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.77368386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 4.90709558 |
| 2 | MAP4K1 | 4.21239800 |
| 3 | TXK | 3.53536485 |
| 4 | KDR | 3.38309528 |
| 5 | RIPK4 | 3.32374706 |
| 6 | ITK | 2.99728014 |
| 7 | FES | 2.92714837 |
| 8 | ZAP70 | 2.85939221 |
| 9 | STK16 | 2.69126883 |
| 10 | MAP3K3 | 2.67612346 |
| 11 | MAP2K3 | 2.58857912 |
| 12 | TAOK2 | 2.23534578 |
| 13 | TAOK3 | 2.17066338 |
| 14 | MAP3K11 | 2.10041409 |
| 15 | BTK | 2.00040235 |
| 16 | TEC | 1.80969625 |
| 17 | PASK | 1.77666090 |
| 18 | CSK | 1.76577796 |
| 19 | STK24 | 1.73774148 |
| 20 | IKBKE | 1.62264607 |
| 21 | SYK | 1.59535139 |
| 22 | LCK | 1.57437937 |
| 23 | TRPM7 | 1.56016186 |
| 24 | TAOK1 | 1.51449935 |
| 25 | EPHB1 | 1.48175783 |
| 26 | ADRBK2 | 1.47009916 |
| 27 | PIM1 | 1.44932720 |
| 28 | TESK2 | 1.42349129 |
| 29 | BLK | 1.41038743 |
| 30 | GRK6 | 1.39666934 |
| 31 | MARK3 | 1.36822133 |
| 32 | TGFBR2 | 1.33716041 |
| 33 | JAK3 | 1.29604876 |
| 34 | MAP3K12 | 1.28366783 |
| 35 | HCK | 1.23782184 |
| 36 | LYN | 1.23742734 |
| 37 | STK38L | 1.23559537 |
| 38 | TYK2 | 1.21981186 |
| 39 | TNK2 | 1.14628027 |
| 40 | JAK1 | 1.14153815 |
| 41 | DAPK2 | 1.12526260 |
| 42 | HIPK2 | 1.11839284 |
| 43 | CSF1R | 1.11647252 |
| 44 | MAP2K6 | 1.08743910 |
| 45 | IKBKB | 0.94625666 |
| 46 | DAPK1 | 0.94087297 |
| 47 | MYLK | 0.89263246 |
| 48 | CAMKK1 | 0.86068625 |
| 49 | CAMKK2 | 0.84583583 |
| 50 | PRKCQ | 0.84154340 |
| 51 | STK10 | 0.81646628 |
| 52 | FRK | 0.79483054 |
| 53 | KIT | 0.77498745 |
| 54 | MST4 | 0.74598232 |
| 55 | MAP3K7 | 0.70051238 |
| 56 | BCR | 0.69351782 |
| 57 | BMPR2 | 0.67742162 |
| 58 | PIK3CG | 0.66911745 |
| 59 | MAP3K14 | 0.64359100 |
| 60 | AKT3 | 0.62975333 |
| 61 | GRK7 | 0.58460362 |
| 62 | ERBB3 | 0.54992445 |
| 63 | PINK1 | 0.52523931 |
| 64 | STK38 | 0.49091428 |
| 65 | NEK6 | 0.47969851 |
| 66 | TIE1 | 0.45130853 |
| 67 | FGR | 0.44937780 |
| 68 | STK4 | 0.43562372 |
| 69 | MAP3K5 | 0.43044620 |
| 70 | DYRK2 | 0.40788077 |
| 71 | ADRBK1 | 0.39744772 |
| 72 | IGF1R | 0.39191772 |
| 73 | TLK1 | 0.39016812 |
| 74 | CDK4 | 0.38151755 |
| 75 | PDK1 | 0.37896223 |
| 76 | TESK1 | 0.36962361 |
| 77 | INSR | 0.35298018 |
| 78 | FGFR4 | 0.35122076 |
| 79 | NLK | 0.33639991 |
| 80 | IRAK1 | 0.32404172 |
| 81 | FYN | 0.32248938 |
| 82 | JAK2 | 0.32217446 |
| 83 | ABL1 | 0.30846707 |
| 84 | PAK3 | 0.29513768 |
| 85 | DAPK3 | 0.29202019 |
| 86 | PRPF4B | 0.28653227 |
| 87 | TBK1 | 0.28297294 |
| 88 | IRAK4 | 0.27631975 |
| 89 | EGFR | 0.26821378 |
| 90 | BUB1 | 0.26054196 |
| 91 | CLK1 | 0.25514613 |
| 92 | MAPKAPK2 | 0.25107809 |
| 93 | PIM2 | 0.24583776 |
| 94 | PRKCH | 0.21304475 |
| 95 | OBSCN | 0.20624312 |
| 96 | NUAK1 | 0.19479969 |
| 97 | INSRR | 0.19015758 |
| 98 | FGFR3 | 0.17889138 |
| 99 | TYRO3 | 0.15848725 |
| 100 | PRKCD | 0.14297310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.32033384 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.77240946 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.54188846 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.41245140 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.19380864 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.97037919 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.80045452 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.64335729 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.46039837 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35694915 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33468654 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.26535109 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19914769 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.03272816 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.95523472 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.90808994 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59103701 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57576664 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55723717 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52293348 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.43940444 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42290126 |
| 23 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.32792440 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.32602413 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27545829 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25329703 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25014262 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23691817 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21225544 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20231925 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15557698 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.11169037 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05182846 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03024997 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99832395 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97503505 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97162958 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91472623 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86266979 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85097682 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84209620 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79259478 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75472516 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75096774 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70950153 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.70263691 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69015827 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68335536 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.67506437 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65770402 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64686122 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.63192509 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62336907 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60427369 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59031368 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.57515513 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51987962 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.51967323 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.51737236 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51385449 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50190730 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47222001 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43867142 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.42563157 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42259806 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40102268 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37821598 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34363489 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33442746 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.33284919 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.33193283 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32645430 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.32229883 |
| 74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32126113 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30926968 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30439613 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29825261 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29753370 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.29588441 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.29426669 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28213266 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27312245 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27259331 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.26107048 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25252629 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.24301453 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.23735117 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23645412 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.22206499 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.22101893 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20575957 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19279155 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.18748104 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18501174 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17907302 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17715175 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16188285 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15804360 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13446288 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.11615394 |

